I-Mab Biopharma
IMAB
#9469
Rank
โ‚ฌ50.55 M
Marketcap
0,62ย โ‚ฌ
Share price
-6.87%
Change (1 day)
-62.65%
Change (1 year)

Earnings for I-Mab Biopharma (IMAB)

Earnings in 2024 (TTM): -โ‚ฌ0.18 Billion

According to I-Mab Biopharma's latest financial reports the company's current earnings are โ‚ฌ3.58 Million. In 2023 the company made an earning of -โ‚ฌ26.68 Million, an increase over its 2022 earnings that were of -โ‚ฌ48.06 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for I-Mab Biopharma from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.18 Billion569.36%
2023 -โ‚ฌ26.68 Million-44.5%
2022-โ‚ฌ48.06 Million-8.36%
2021-โ‚ฌ52.44 Million-605.96%
2020 โ‚ฌ10.36 M-138.32%
2019 -โ‚ฌ27.05 Million260.14%
2018 -โ‚ฌ7.51 Million19.49%
2017-โ‚ฌ6.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ16.57 Million-90.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ9.46 Million-94.74%๐Ÿ‡บ๐Ÿ‡ธ USA